Dexia : Invitation to attend the Ordinary General Meeting

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
149
Dexia : Invitation to attend the Ordinary General Meeting and an Extraordinary General Meeting of Dexia SA

Regulated information - Brussels, Paris, 14 April 2017 - 8 am

Invitation to attend the Ordinary General Meeting and an Extraordinary General Meeting of Dexia SA

The Ordinary General Meeting and an Extraordinary General Meeting of Dexia SA will be held on Wednesday 17 May 2017 at 2:30 pm at the registered office of Dexia at Place du Champ de Mars 5, 1050 Brussels. Reception will be open from 1:30 pm, and shareholders may register between 1:30 and 2:15 pm.

The invitation to attend the General Meetings containing the agenda and the proposed resolutions has been published today in the official journals and in the Belgian, French and Luxembourg press.

All appropriate documents are available on the company's internet site at: http://www.dexia.com/EN/shareholder_investor/...fault.aspx , and include:

  • the invitation brochure,
  • the annual report 2016,
  • the attendance, correspondence voting and proxy forms.

Any question relating to the meetings may be sent to the company at the following email address shareholder@dexia.com

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...77f2b61e26

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Monitor Class Action Against Xerox Ahead of Deadline

Updated Category News Views 313

Xerox Holdings Corporation Under Legal Scrutiny Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors of Xerox Holdings Corporation (NASDAQ: XRX) to inform them about an ongoing class action lawsuit. Investors are reminded of an important deadline for those wanting to assume the role of lead plaintiff in this case. The deadline for...

Continue Reading
UBS's Caution on Dr. Reddy's Projections Signals Concerns

Updated Category News Views 155

UBS dropped a Sell rating on Dr. Reddy's Laboratories (NSE: DRRD) back in 2024, tagging the stock with a price target of INR 5,700.00. You could feel the tension shift in trading rooms as their assessment sparked fresh chatter about the firm’s US base business revenue projections that seem downright optimistic. UBS Questions Revenue Estimates: Too High or Just Right?...

Continue Reading
Evaluating Apple's Business Landscape Among Top Tech Firms

Updated Category News Views 115

Assessing Market Position and Performance In the dynamic world of technology hardware, it’s crucial for investors to analyze the competition thoroughly. This article takes a closer look at Apple (NASDAQ: AAPL) and compares its financial metrics and market position against its key competitors in the industry. With this analysis, we aim to provide insights into Apple's...

Continue Reading
Back to School: Parents Prepare for Illness and Solutions

Updated Category News Views 191

Back to School: Parents Brace for Sickness A recent survey shows that as children head back to the classroom, many parents anticipate facing a wave of illnesses at home. Conducted by Boiron, a leader in homeopathic remedies, this nationwide survey reveals parents' concerns about the inevitable germs that come along with the school year. Survey Insights on Parental...

Continue Reading
Scarf Systems Achieves SOC 2 Type 2 Examination Success

Updated Category News Views 72

Scarf Systems, Inc. completed a SOC 2 Type 2 examination back in early 2023, solidifying its place as a frontrunner in data security. This wasn't just some routine check; it was a deep dive into how well Scarf protected customer data and adhered to stringent safety protocols. But here’s the kicker—traders started asking: is this enough to keep investors calm? What’s...

Continue Reading